Extra radiation boost shows promise for bulky cervical cancer

NCT ID NCT07435376

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase 2 trial is testing whether adding a precise radiation boost to standard treatment can shrink large cervical tumors more effectively. Seventeen participants with bulky squamous cell carcinoma will receive external radiation plus a targeted boost, followed by internal brachytherapy. The main goal is to see if the boost reduces tumor volume enough before brachytherapy, while also monitoring side effects.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
radiation therapy (intra-lesional boost IMRT and high-dose-rate brachytherapy)
What this could lead to
If successful, this approach could improve tumor shrinkage before brachytherapy, potentially leading to better local control and outcomes for patients with bulky cervical cancer.
What could go wrong
This is a small, early-phase trial with only 17 participants, so results may not apply broadly. The extra radiation could increase side effects, and it's unclear if it will improve long-term survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.